CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice

The main challenge of adoptive therapy with Chimeric Antigen Receptor modified T cells (CAR T) is the application to the field of solid tumors, where the identification of a proper antigen has emerged as one of the major drawbacks to CAR T cell treatment success. CD44 is a glycoprotein involved in c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Porcellini, Simona, Asperti, Claudia, Corna, Stefano, Cicoria, Eleonora, Valtolina, Veronica, Stornaiuolo, Anna, Valentinis, Barbara, Bordignon, Claudio, Traversari, Catia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7010926/
https://ncbi.nlm.nih.gov/pubmed/32117253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00099
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak